NexGel Seeks Shareholder Approval for Reverse Split and Up to 150M Authorized Shares
NXGL sits 73% above its 52-week low of $0.33 on elevated volume (4.9× avg).
Summary
NexGel filed a preliminary proxy seeking approval for a reverse stock split and an increase in authorized shares to up to 150 million, aiming to regain Nasdaq compliance and provide financing flexibility.
Key Events · Corporate Governance and Compliance · NXGL
-
Reverse Stock Split Proposed
Board seeks approval for a discretionary reverse split at a ratio of 1-for-2 to 1-for-20 to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The stock currently trades at $0.57, and the compliance deadline is October 19, 2026.
-
Authorized Share Increase Capped at 150M
Proposal 1 would increase authorized common shares from 25 million to up to 150 million, with the board having discretion to set the exact number. This is a material change from the prior proxy's 'potentially unlimited dilution' language.
-
Special Meeting Set for September 23
Shareholders will vote on the proposals at a special meeting on September 23, 2026, with a record date of August 21, 2026. The board recommends voting FOR all proposals.
-
Nasdaq Delisting Risk
The company received a deficiency letter on April 22, 2026, for trading below $1.00. If compliance is not regained by October 19, 2026, the stock faces delisting from Nasdaq.
Analysis · NXGL · Industrial Applications And Services
NexGel is asking shareholders to approve a discretionary reverse stock split (1-for-2 to 1-for-20) to regain Nasdaq compliance, alongside an increase in authorized shares from 25 million to up to 150 million. The reverse split is a new proposal not previously disclosed, and the authorized share cap provides clarity on potential dilution. With the stock trading at $0.57, the reverse split is critical to avoid delisting by the October 19, 2026 deadline.
At the time of this filing, NXGL was trading at $0.57 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.33 to $2.89. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.